Increased arterial standard bicarbonate is associated with hypertension in patients with obstructive sleep apnea – data from the European Sleep Apnea DatAbase (ESADA)

D. Zou (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), O. Basoglu (Izmir, Turkey), J. Verbraecken (Antwerp, Belgium), S. Schiza (Heraklion, Greece), P. Sliwinski (Warsaw, Poland), P. Steiropoulos (Alexandroupolis, Greece), H. Hein (Reinbeck, Germany), J. Pépin (Grenoble, France), G. Parati (Milan, Italy), W. Mcnicholas (Dublin, Ireland), J. Hedner (Gothenburg, Sweden)

Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Session: Insights into the pathophysiology of sleep-disordered breathing
Session type: Oral Presentation
Number: 4933
Disease area: Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Zou (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), O. Basoglu (Izmir, Turkey), J. Verbraecken (Antwerp, Belgium), S. Schiza (Heraklion, Greece), P. Sliwinski (Warsaw, Poland), P. Steiropoulos (Alexandroupolis, Greece), H. Hein (Reinbeck, Germany), J. Pépin (Grenoble, France), G. Parati (Milan, Italy), W. Mcnicholas (Dublin, Ireland), J. Hedner (Gothenburg, Sweden). Increased arterial standard bicarbonate is associated with hypertension in patients with obstructive sleep apnea – data from the European Sleep Apnea DatAbase (ESADA). 4933

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Independent associations between arterial bicarbonate, apnea severity and hypertension in a sleep apnea cohort
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Mild obstructive sleep apnoea (OSA) and arterial hypertension in the EuropeanSleep Apnoea Database (ESADA) cohort study.
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018



Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: Longitudinal data from the European Sleep Apnea Database (ESADA)
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017

Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA)
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021

Relationship of arterial hypertension and obstructive sleep apnea syndrome
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014

Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013

Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS)
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015


Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome
Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing
Year: 2014

Adherence to continuous positive airway pressure therapy (CPAP) in patients with obstructive sleep apnea (OSA) in an Asian privately funded healthcare system
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Predictors of titrating pressure using A-CPAP in obstructive sleep apnea
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015


Nocturia is an independent predictive factor of prevalent hypertension in obstructive sleep apnea patients
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014


Weight changes in patients with obstructive sleep apnoea syndrome (OSAS) before and after CPAP
Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly
Year: 2014


Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA)
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Daytime sleepiness and cardiovascular complications in moderate to severe obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013


Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 562s
Year: 2002

Retrospective analysis of oxygen therapy in persistent nocturnal hypoxia despite CPAP in obstructive sleep apnoea syndrome (OSAS)
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014


Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015


Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Association between coronary artery disease (CAD) and heart failure and age in obstructive sleep apnoea (OSA) patients
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Resistant hypertension and obstructive sleep apnea
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013